TY - JOUR
T1 - Combined diabetes and arthritis are associated with declined gait speed
AU - Alenazi, Aqeel M.
AU - Alshehri, Mohammed M.
AU - Alqahtani, Bader A.
AU - Alanazi, Ahmad D.
AU - Bindawas, Saad M.
N1 - Publisher Copyright:
© 2020, International League of Associations for Rheumatology (ILAR).
PY - 2021/4
Y1 - 2021/4
N2 - This study investigated the association of combined arthritis and diabetes, diabetes only, and arthritis only compared with neither with gait speed in the general population. This cross-sectional study included data from the second wave of Midlife in the United States-2 (MIDUS 2) project 4: Biomarker Project, 2004–2009. The MIDUS 2 biomarker project included 1255 individuals aged between 34 and 84 years. Participants were categorized into four groups: combined arthritis and diabetes, diabetes only, arthritis only, or neither. The main outcome measure was gait speed measured by the 50-ft walk test. Covariates included age, gender, body mass index (BMI), depression symptoms, and number of chronic conditions/symptoms. A total of 1255 participants were included with mean age 54.52 ± 11.71, of those 713 (56.8%) participants were females. The results showed that combined arthritis and diabetes was significantly associated with a greater decline in gait speed (B = − 0.11, 95% confidence interval (CI) [− 0.17 to − 0.6], p < 0.001). Arthritis and diabetes were independently significantly associated with decreased gait speed (B = − 0.072, 95% CI [− 0.10 to − 0.043], p < 0.001), (B = − 0.064, 95% CI [− 0.12 to − 0.012], p = 0.015), respectively. Combined arthritis and diabetes was associated with a greater decline in gait speed compared with diabetes only, arthritis only, or neither group.Key Points• Combined arthritis and diabetes were associated with declined gait speed.• Gait speed did not differ between people with arthritis compared with people with diabetes.• We recommended including gait speed assessment in regular clinical visits to capture gait speed declines for further health assessments.
AB - This study investigated the association of combined arthritis and diabetes, diabetes only, and arthritis only compared with neither with gait speed in the general population. This cross-sectional study included data from the second wave of Midlife in the United States-2 (MIDUS 2) project 4: Biomarker Project, 2004–2009. The MIDUS 2 biomarker project included 1255 individuals aged between 34 and 84 years. Participants were categorized into four groups: combined arthritis and diabetes, diabetes only, arthritis only, or neither. The main outcome measure was gait speed measured by the 50-ft walk test. Covariates included age, gender, body mass index (BMI), depression symptoms, and number of chronic conditions/symptoms. A total of 1255 participants were included with mean age 54.52 ± 11.71, of those 713 (56.8%) participants were females. The results showed that combined arthritis and diabetes was significantly associated with a greater decline in gait speed (B = − 0.11, 95% confidence interval (CI) [− 0.17 to − 0.6], p < 0.001). Arthritis and diabetes were independently significantly associated with decreased gait speed (B = − 0.072, 95% CI [− 0.10 to − 0.043], p < 0.001), (B = − 0.064, 95% CI [− 0.12 to − 0.012], p = 0.015), respectively. Combined arthritis and diabetes was associated with a greater decline in gait speed compared with diabetes only, arthritis only, or neither group.Key Points• Combined arthritis and diabetes were associated with declined gait speed.• Gait speed did not differ between people with arthritis compared with people with diabetes.• We recommended including gait speed assessment in regular clinical visits to capture gait speed declines for further health assessments.
KW - Arthritis
KW - Diabetics
KW - Walking speed
UR - http://www.scopus.com/inward/record.url?scp=85089889429&partnerID=8YFLogxK
U2 - 10.1007/s10067-020-05370-3
DO - 10.1007/s10067-020-05370-3
M3 - Article
C2 - 32856200
AN - SCOPUS:85089889429
SN - 0770-3198
VL - 40
SP - 1593
EP - 1598
JO - Clinical Rheumatology
JF - Clinical Rheumatology
IS - 4
ER -